| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group
|
Mostert, Saskia
|
|
2011
|
12 |
8 |
p. 719-720
2 p.
|
artikel
|
| 2 |
Are all KRAS mutations created equal?
|
Stinchcombe, Thomas E
|
|
2011
|
12 |
8 |
p. 717-718
2 p.
|
artikel
|
| 3 |
Association between KRAS rs61764370 and triple-negative breast cancer—a false positive?
|
Pharoah, Paul
|
|
2011
|
12 |
8 |
p. 723-724
2 p.
|
artikel
|
| 4 |
Association between KRAS rs61764370 and triple-negative breast cancer—a false positive? – Authors' reply
|
Weidhaas, Joanne
|
|
2011
|
12 |
8 |
p. 724-
1 p.
|
artikel
|
| 5 |
Attenuated immunochemotherapy for diffuse large B-cell lymphoma
|
Miura, Katsuhiro
|
|
2011
|
12 |
8 |
p. 725-
1 p.
|
artikel
|
| 6 |
Attenuated immunochemotherapy for diffuse large B-cell lymphoma – Authors' reply
|
Peyrade, Frédéric
|
|
2011
|
12 |
8 |
p. 725-726
2 p.
|
artikel
|
| 7 |
Bevacizumab: public opinion might trump science
|
Carlson, Robert H
|
|
2011
|
12 |
8 |
p. 730-
1 p.
|
artikel
|
| 8 |
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
|
Coiffier, Bertrand
|
|
2011
|
12 |
8 |
p. 773-784
12 p.
|
artikel
|
| 9 |
Cigarettes and plain packaging: the battle lines are drawn
|
The Lancet Oncology,
|
|
2011
|
12 |
8 |
p. 709-
1 p.
|
artikel
|
| 10 |
Dignity therapy for patients who are terminally ill
|
Nekolaichuk, Cheryl L
|
|
2011
|
12 |
8 |
p. 712-713
2 p.
|
artikel
|
| 11 |
Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial
|
Chochinov, Harvey Max
|
|
2011
|
12 |
8 |
p. 753-762
10 p.
|
artikel
|
| 12 |
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
|
Morgan, Gareth J
|
|
2011
|
12 |
8 |
p. 743-752
10 p.
|
artikel
|
| 13 |
Erlotinib, gefitinib, or chemotherapy for EGFR mutation-positive lung cancer?
|
Mitsudomi, Tetsuya
|
|
2011
|
12 |
8 |
p. 710-711
2 p.
|
artikel
|
| 14 |
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|
Zhou, Caicun
|
|
2011
|
12 |
8 |
p. 735-742
8 p.
|
artikel
|
| 15 |
Errata
|
|
|
2011
|
12 |
8 |
p. 722-
1 p.
|
artikel
|
| 16 |
Errata
|
|
|
2011
|
12 |
8 |
p. 722-
1 p.
|
artikel
|
| 17 |
Ethical assessment of life-prolonging treatment
|
Winkler, Eva C
|
|
2011
|
12 |
8 |
p. 720-722
3 p.
|
artikel
|
| 18 |
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
|
Treasure, Tom
|
|
2011
|
12 |
8 |
p. 763-772
10 p.
|
artikel
|
| 19 |
Height and cancer: consistent links, but mechanisms unclear
|
Renehan, Andrew G
|
|
2011
|
12 |
8 |
p. 716-717
2 p.
|
artikel
|
| 20 |
Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk
|
Green, Jane
|
|
2011
|
12 |
8 |
p. 785-794
10 p.
|
artikel
|
| 21 |
Is industry influencing carcinogen assessments in the USA?
|
Furlow, Bryant
|
|
2011
|
12 |
8 |
p. 731-732
2 p.
|
artikel
|
| 22 |
Japan's nuclear crisis
|
Yoshiuchi, Kazuhiro
|
|
2011
|
12 |
8 |
p. 724-725
2 p.
|
artikel
|
| 23 |
LIFE Before Death
|
Burki, Talha
|
|
2011
|
12 |
8 |
p. 733-734
2 p.
|
artikel
|
| 24 |
Management of uncommon chemotherapy-induced emergencies
|
Morgan, Carys
|
|
2011
|
12 |
8 |
p. 806-814
9 p.
|
artikel
|
| 25 |
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
|
O'Byrne, Kenneth J
|
|
2011
|
12 |
8 |
p. 795-805
11 p.
|
artikel
|
| 26 |
NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer
|
Rinaldi, Fiona
|
|
2011
|
12 |
8 |
p. 728-730
3 p.
|
artikel
|
| 27 |
3rd congress of the International Academy of Oral Oncology
|
Ceschia, Audrey
|
|
2011
|
12 |
8 |
p. 732-
1 p.
|
artikel
|
| 28 |
Surgery for mesothelioma? The debate continues
|
Kindler, Hedy Lee
|
|
2011
|
12 |
8 |
p. 713-714
2 p.
|
artikel
|
| 29 |
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
|
Laurie, Scott A
|
|
2011
|
12 |
8 |
p. 815-824
10 p.
|
artikel
|
| 30 |
The challenge of recurrent follicular lymphoma
|
Tomás, José F
|
|
2011
|
12 |
8 |
p. 714-716
3 p.
|
artikel
|
| 31 |
US physician whistleblowers face intimidation and retaliation
|
Furlow, Bryant
|
|
2011
|
12 |
8 |
p. 727-
1 p.
|
artikel
|
| 32 |
Zoledronic acid for all patients with newly diagnosed multiple myeloma?
|
Terpos, Evangelos
|
|
2011
|
12 |
8 |
p. 711-712
2 p.
|
artikel
|
Tijdschrift beschrijving